OBJECTIVE: This study examined the long-term effects of fluoxetine administered to juvenile rhesus monkeys who, as young adults, were imaged with positron emission tomography for two serotonergic markers: serotonin transporter (SERT) and serotonin 1A (5-HT1A) receptor. An equal number of monkeys separated from their mothers at birth-an animal model of human childhood stress-were also studied. METHOD: At birth, 32 male rhesus monkeys were randomly assigned to either maternal separation or normal rearing conditions. At age 2, half (N=8) of each group was randomly assigned to fluoxetine (3 mg/kg) or placebo for 1 year. To eliminate the confounding effects of residual drug in the brain, monkeys were scanned at least 1.5 years after drug discontinuation. Social interactions were assessed both during and after drug administration. RESULTS: Fluoxetine persistently upregulated SERT, but not 5-HT1A receptors, in both the neocortex and the hippocampus. Whole-brain voxel-wise analysis revealed that fluoxetine had a significant effect in the lateral temporal and cingulate cortices. In contrast, neither maternal separation by itself nor the rearing-by-drug interaction was significant for either marker. Fluoxetine had no significant effect on the behavioral measures. CONCLUSIONS: Fluoxetine administered to juvenile monkeys upregulates SERT into young adulthood. Implications regarding the efficacy or potential adverse effects of SSRIs in patients cannot be directly drawn from this study. Its purpose was to investigate effects of SSRIs on brain development in nonhuman primates using an experimental approach that randomly assigned long-term SSRI treatment or placebo.
OBJECTIVE: This study examined the long-term effects of fluoxetine administered to juvenile rhesus monkeys who, as young adults, were imaged with positron emission tomography for two serotonergic markers: serotonin transporter (SERT) and serotonin 1A (5-HT1A) receptor. An equal number of monkeys separated from their mothers at birth-an animal model of human childhood stress-were also studied. METHOD: At birth, 32 male rhesus monkeys were randomly assigned to either maternal separation or normal rearing conditions. At age 2, half (N=8) of each group was randomly assigned to fluoxetine (3 mg/kg) or placebo for 1 year. To eliminate the confounding effects of residual drug in the brain, monkeys were scanned at least 1.5 years after drug discontinuation. Social interactions were assessed both during and after drug administration. RESULTS:Fluoxetine persistently upregulated SERT, but not 5-HT1A receptors, in both the neocortex and the hippocampus. Whole-brain voxel-wise analysis revealed that fluoxetine had a significant effect in the lateral temporal and cingulate cortices. In contrast, neither maternal separation by itself nor the rearing-by-drug interaction was significant for either marker. Fluoxetine had no significant effect on the behavioral measures. CONCLUSIONS:Fluoxetine administered to juvenile monkeys upregulates SERT into young adulthood. Implications regarding the efficacy or potential adverse effects of SSRIs in patients cannot be directly drawn from this study. Its purpose was to investigate effects of SSRIs on brain development in nonhuman primates using an experimental approach that randomly assigned long-term SSRI treatment or placebo.
Authors: Catherine E Barrett; Pamela Noble; Erin Hanson; Daniel S Pine; James T Winslow; Eric E Nelson Journal: Psychoneuroendocrinology Date: 2009-03-05 Impact factor: 4.905
Authors: Simona Spinelli; Svetlana Chefer; Richard E Carson; Elaine Jagoda; Lixin Lang; Markus Heilig; Christina S Barr; Stephen J Suomi; J Dee Higley; Elliot A Stein Journal: Biol Psychiatry Date: 2010-02-20 Impact factor: 13.382
Authors: Nitin Gogtay; Allen Lu; Alex D Leow; Andrea D Klunder; Agatha D Lee; Alex Chavez; Deanna Greenstein; Jay N Giedd; Arthur W Toga; Judith L Rapoport; Paul M Thompson Journal: Proc Natl Acad Sci U S A Date: 2008-10-13 Impact factor: 11.205
Authors: Eric E Nelson; Khalisa N Herman; Catherine E Barrett; Pamela L Noble; Kimberly Wojteczko; Kelli Chisholm; Deborah Delaney; Monique Ernst; Nathan A Fox; Stephen J Suomi; James T Winslow; Daniel S Pine Journal: Biol Psychiatry Date: 2009-05-17 Impact factor: 13.382
Authors: H P Jedema; P J Gianaros; P J Greer; D D Kerr; S Liu; J D Higley; S J Suomi; A S Olsen; J N Porter; B J Lopresti; A R Hariri; C W Bradberry Journal: Mol Psychiatry Date: 2009-09-01 Impact factor: 15.992
Authors: Francisco J Flores-Ramirez; Lyonna F Parise; Jason B Alipio; Israel Garcia-Carachure; Samuel A Castillo; Minerva Rodriguez; Anapaula Themman; Omar Lira; Joshua Preciado-Piña; Sergio D Iñiguez Journal: J Affect Disord Date: 2019-02-19 Impact factor: 4.839
Authors: Iva Dincheva; Jianmin Yang; Anfei Li; Tina Marinic; Helena Freilingsdorf; Chienchun Huang; B J Casey; Barbara Hempstead; Charles E Glatt; Francis S Lee; Kevin G Bath; Deqiang Jing Journal: Am J Psychiatry Date: 2017-10-31 Impact factor: 18.112
Authors: Shu-Yi Su; Casey E Hogrefe-Phi; John M Asara; Christoph W Turck; Mari S Golub Journal: Eur Neuropsychopharmacol Date: 2016-04-12 Impact factor: 4.600